Skip to content
Search

Latest Stories

GPhC fitness to practise committee suspends a pharmacist for four months

The General Pharmaceutical Council (GPhC) Fitness to Practise Committee has suspended a pharmacist for four months after been found guilty of misconduct of removing bottles of codeine linctus without pharmacy owner's permission.

The Committee was of the view that an order of suspension was the appropriate and proportionate sanction to send an appropriate and clear message to professionals and to the public of the seriousness with which the regulator takes the pharmacist's misconduct.


"This will ensure that the public can continue to have confidence in the profession, uphold professional standards and maintain the public’s confidence in the Regulator itself," said committee.

Abdalla Mohammed Abdallo a pharmacist first registered on 15 August 2014 with the General Pharmaceutical Council under the registration number 2083625. On 27 October 2020, whilst working as a locum pharmacist at Tuebrook Pharmacy, the pharmacist ordered four 200ml bottles of codeine linctus SF and removed four 200ml bottles of codeine linctus SF from Tuebrook Pharmacy without making payment.

On 28 October 2020, whilst working as a locum pharmacist at Upton Rocks Pharmacy, he ordered four bottles of 200ml codeine linctus BP; removed 4 bottles of 200ml codeine linctus BP from Upton Pharmacy without making payment. He also removed four 200ml codeine linctus BP from Upton Pharmacy without permission from the owner.

In relation to the appropriate length of suspension, the Committee took into account the pharmacist’s difficult personal circumstances at the time. The Committee alsoexpressed the view that these matters do not excuse his misconduct, however they are mitigating factors.

The Committee has also taken into account that the pharmacist has been subject to interim orders for over two years, and for the majority of that time he has been subject to interim suspension.

Therefore, the Committee decided that a short period of suspension of four months is appropriate and proportionate in all the circumstances. The hearing was conducted on 13-16 March 2023 & 6-8 June 2023.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less